INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hema...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Oct 30, 2025